Bioinorganic chemistry development

Upon completion of his Ph.D., he was appointed in 2001 as a Ingenieur in the CNRS in the Laboratory of Bioorganic and Bioinorganic Chemistry, at the Institute of Molecular Chemistry and Materials at Orsay (ICMMO) at the University of Paris 11 (France), where he first went on to develop the field of hemoabzymes. 

Metal complexes of stable carbenes—or more precisely metal complexes of car-benes that are now known to be stable—have developed from laboratory curiosities to widely used compounds. The basis for this development was laid by Wanzlick s and Ofele s discoveries in the 1960s, the recent revival has certainly been driven by Arduengo s first isolation of an A-heterocyclic carbene in 1991, and the result is a permanently increasing number of synthetic routes towards precursors for stable carbenes, towards stable carbenes themselves, and their metal complexes. Simultaneously with their accessibility, the applicability of these compounds to various fields such as homogeneous catalysis, materials science, medicinal and bioinorganic chemistry has been evaluated. 

The reported data as far as Zn NMR is concerned are sporadic, and very limited due to difficulties from a technical point of view, the nature of the Zn nucleus, as well as all factors responsible for the latter such as concentration, the nature of the proximity ligands etc. A descriptive analysis of the last reported data concerning Zn NMR studies will be developed with respect to the role of Zn ion or element in materials science or bioinorganic chemistry in both solution and solid state. 

It goes without saying that answers to the important questions raised earlier will develop during the next decade. It is hoped that the present monograph will provide a significant contribution to better understanding and will help lead to novel applications of bioinorganic chemistry. 

The bioinorganic chemistry of NO has only developed after the publication of the first edition of this book. Because this book deals with metal catalysis, a discussion of NO does not belong here. However, its reduction with an NO reductase [33] and its synthesis from L-arginine with an NO synthase oxygenase [34] clearly deal with metal heme systems and therefore should be mentioned here as well. 

Bioinorganic chemistry will surely develop in an even wider area than it has thus far. Attention is likely to increase for studies on nonmetals, such as Se and As and their roles in, e.g., detoxification reactions. In addition, studies on elements such as aluminum (a possible causative factor in dialysis dementia and related to Alzheimer disease, senile dementia) and other abundant earth crust metals will increase. The role of bioinorganic catalysis to make and keep our environment clean has been mentioned in many of the previous chapters. It is to be expected that future catalytic processes, based on and derived from biological ones, will be as clean as possible, producing useful, harmless, and biodegradable products for the world. 

I. T. Urasa, Development of new methods of speciation analysis, in S. Caroli (ed.), Element Speciation in Bioinorganic Chemistry, Wiley, New York, 1996, pp. 121-154. 

Mechanistic bioinorganic chemistry / [editors] H. Holden Thorp, Vincent L. Pecoraro developed from a symposium sponsored by the Division of Inorganic Chemistry, Inc., at the 205th National Meeting of the American Chemical Society, Denver, Colorado, March 28-April 2, 1993. 

---